Governance
Governing Board Chairpersons
Prof William Chin
Bertarelli Professor of Translational Medical Science Harvard Medical School
Formerly SVP Discovery Research, Eli Lilly
Formerly SVP Discovery Research, Eli Lilly
Prof Benjamin Seet
Deputy Group Chief Executive Officer &
Group Chief Research Officer
National Healthcare Group
Group Chief Research Officer
National Healthcare Group
Governing Board Members
Prof Damian O’Connell
Chief Executive Officer,
Experimental Drug Development
Centre (EDDC)
Experimental Drug Development
Centre (EDDC)
Prof Tan Sze Wee
Assistant Chief Executive,
Biomedical Research Council (BMRC), A*STAR
Biomedical Research Council (BMRC), A*STAR
Mr John Lim
Chief Executive Officer,
National Research Foundation (NRF)
National Research Foundation (NRF)
Ms Goh Wan Yee
Senior Vice President and –
Head Healthcare,
Economic Development Board (EDB)
Head Healthcare,
Economic Development Board (EDB)
Dr Danny Soon
Chief Executive Officer,
Consortium for Clinical Research & Innovation Singapore(CRIS), Ministry of Health (MOH)
Consortium for Clinical Research & Innovation Singapore(CRIS), Ministry of Health (MOH)
Prof Tan Say Beng
Executive Director,
National Medical Research Council (NMRC)
National Medical Research Council (NMRC)
Ms Irene Cheong
Assistant Chief Executive,
Innovation & Enterprise (I&E), A*STAR
Innovation & Enterprise (I&E), A*STAR
Dr Clarice Chen
Director, Enterprise Singapore (ESG)
Dr Andreas Wallnoefer
Partner Investor, Jeito Capital
Formerly SVP & Global Head of Development, Hoffman-La Roche
Formerly SVP & Global Head of Development, Hoffman-La Roche
Portfolio Review Committee
EDDC is guided by a Portfolio Review Committee (PRC) that advises on EDDC’s portfolio projects and platforms. The PRC reports to EDDC’s Governing Board, and evaluates EDDC’s project milestones, timelines and deliverables. The PRC also provides recommendations for selecting, managing and funding our portfolio of projects.